香港, Feb. 08, 2025 (GLOBE NEWSWIRE) — 總部位於香港的金融服務公司 Plutus Financial Group Limited（以下簡稱「公司」）(NasdaqCM: PLUT) 今天宣佈其首次公開招股（以下簡稱「招股」）的定價。此次招股將發行 210 萬股普通股，公開發售價格為每股 4 美元，未扣除承銷折扣和發售費用的總收益為 840 萬美元。 本次招股以包銷的方式進行。 普通股已於 2025 年 2…
Plutus Financial Group Limited 宣布完成首次公开发行
香港, Feb. 08, 2025 (GLOBE NEWSWIRE) — 总部位于香港的金融服务公司 Plutus Financial Group Limited（以下简称“本公司”）(NasdaqCM：PLUT) 今日宣布完成首次公开发行（以下简称“本次发行”）。本次发行规模为 210 万股普通股，每股公开发行价格为 4 美元，在扣除承销折扣及发行费用前，募集资金总额达 840 万美元。 本次发行采用包销方式。 其普通股于 2025 年 2 月…
McEwen Mining Inc. Prices Upsized Offering of $95 Million of Convertible Senior Notes
TORONTO, Feb. 07, 2025 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (the “Company”) today announced the pricing of $95 million aggregate principal amount of…
Sionna Therapeutics Prices Upsized Initial Public Offering
BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm…
McEwen Mining Inc. Announces Proposed Offering of $85 Million of Convertible Senior Notes
TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) (the “Company”) today announced its intention to offer, subject to market…
Huachen AI Parking Management Technology Holding Co., Ltd Announces Closing of Initial Public Offering
JIAXING, CHINA, Feb. 06, 2025 (GLOBE NEWSWIRE) — Huachen AI Parking Management Technology Holding Co., Ltd (the “Company”) (NASDAQ: HCAI), a comprehensive smart parking solutions…
Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study
QUANTUM BIOPHARMA PARTNER CELLY NUTRITION RETAINS LEADING NEW YORK INVESTMENT BANK TO ADVISE ON CAPITAL RAISE AND POSSIBLE INITIAL PUBLIC OFFERING FOLLOWIN Source: Quantum Biopharma…
Mustang Bio Announces Pricing of $8 Million Public Offering
WORCESTER, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s…
BriaCell Therapeutics Announces Closing of Public Offering
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage…
GH Research Announces Pricing of $150 Million Public Offering
DUBLIN, Feb. 05, 2025 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing…
BriaCell Therapeutics Announces Pricing of Public Offering
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage…
BriaCell Therapeutics Announces Proposed Public Offering of Common Shares
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage…
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today…
Stellar V Capital Corp. Announces Closing of $150 Million Initial Public Offering
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) — Stellar V Capital Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman…
Metsera Announces Pricing of Initial Public Offering
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone…
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering
IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the…
MRF 2025 Resource Limited Partnership: Closing February 25, 2025 – Maximum $50,000,000
TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Middlefield, on behalf of MRF 2025 Resource Limited Partnership (“MRF 2025” or the “Partnership”), is pleased to announce…
Ascentage Pharma Announces Closing of U.S. Initial Public Offering
ROCKVILLE, Md. and SUZHOU, China, Jan. 28, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the closing of its U.S. initial…
Skyline Builders Group Holding Limited Announces Closing of Approximately $6 Million Initial Public Offering
Hong Kong, Jan. 24, 2025 (GLOBE NEWSWIRE) — Skyline Builders Group Holding Limited (NASDAQ: SKBL) (the “Company”), a civil engineering services provider in Hong Kong,…
Ascentage Pharma Announces Pricing of U.S. Initial Public Offering
ROCKVILLE, Md. and SUZHOU, China, Jan. 23, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S. initial…